drugset / Trial / NCT04176705
Fractional Ablative Laser Treatment for Skin Grafts
RandomizedParallel-groupOpen-labelTreatment
Summary
Doctors and patients refer to all areas of skin changes from burn injury as burn scars. However, different areas of scars from burns can be treated differently. The burn scars that come from skin grafting surgery might be improved with laser treatment. The purpose of this study is to see if treating burn skin graft scars with a laser could make it better. Fractional Ablative Laser has been approved by the US Food and Drug Administration (FDA), but it has not been approved for use in the early stages of scar maturation and is considered investigational for this study.
Timeline
- Start
- 2020-12-14
- Primary completion
- 2023-09-29
- Completion
- 2023-09-29
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Background | Lidocaine | Other / unclassified | 4 % | Topical |
| Background | Triamcinolone Acetonide | Other / unclassified | 20 mg/ml | Topical |
Indications
No indication recorded.